Abstract Schizophrenia is considered a debilitating neurodevelopmental psychiatric disorder and its pharmacotherapy remains problematic without recent major advances. The development…
Abstract While cannabis is perceived as a relatively safe drug by the public, accumulating clinical data suggest detrimental cardiovascular effects…
Abstract Much of our knowledge of the endocannabinoid system in schizophrenia comes from behavioral measures in rodents, like prepulse inhibition…
Abstract Smoking is the most common route of administration for cannabis; however, vaping cannabis extracts and synthetic cannabinoids (“fake marijuana”)…
Abstract BACKGROUND: Panic disorder (PD) is a disabling psychiatry condition that affects approximately 5% of the worldwide population. Currently, long-term…
Abstract There is urgent need for the development of mechanistically different and less side-effect prone antipsychotic compounds. The endocannabinoid system…
Abstract Schizophrenia is a severe psychiatric disorder that involves positive, negative and cognitive symptoms. Prepulse inhibition of startle reflex (PPI)…
Abstract The goal of this review is to summarize current evidence for sex differences in the response to cannabinoid compounds,…
Abstract Cannabis has long been known to produce cognitive and emotional effects. Research has shown that cannabinoid drugs produce these…
Abstract The reversibility of hepatic histological damage after restoring bile flow in a murine model was assessed. 25 male Balb…